China’s Factory Activity Contracts Unexpectedly in July as COVID Flares Up

China’s factory activity contracted unexpectedly in July after bouncing back from COVID-19 lockdowns the month before, as fresh virus flare-ups and a darkening global outlook weighed on demand, a survey showed on Sunday.

The official manufacturing purchasing managers’ Index (PMI) fell to 49.0 in July from 50.2 in June, the National Bureau of Statistics (NBS) said, below the 50-point mark that separates contraction from growth and the lowest in three months.

Analysts polled by Reuters had expected a reading of 50.4.

“The level of economic prosperity in China has fallen, the foundation for recovery still needs consolidation,” NBS senior statistician Zhao Qinghe said in a statement on the NBS website.

Continued contraction in the energy-intensive industries, such as petrol, coking coal and ferrous metals, contributed most to pulling down the July manufacturing PMI, he said.

Sub-indexes for output and new orders fell by 3 points and about 2 points in July, respectively, while the employment sub-index edged down by 0.1 point.

Weak demand has constrained recovery, Bruce Pang, chief economist and head of research at Jones Lang Lasalle Inc, said in a research note. “Q3 growth may face greater challenges than expected, as recovery is slow and fragile,” he added.

The official non-manufacturing PMI in July fell to 53.8 from 54.7 in June. The official composite PMI, which includes manufacturing and services, fell to 52.5 from 54.1.

China’s economy barely grew in the second quarter amid widespread lockdowns, and top leaders recently signaled their strict zero-COVID policy would remain a top priority.

Policymakers are prepared to miss their GDP growth target of “around 5.5%” for this year, state media reported after a high-level meeting of the ruling Communist Party.

Beijing’s decision to drop mention of the target has doused speculation that the authorities would roll out massive stimulus measures, as they often have in previous downturns.

Capital Economics says that policy restraint, along with the constant threat of more lockdowns and weak consumer confidence, is likely to make China’s economic recovery more drawn-out.

Faltering recovery

After a rebound in June, the recovery in the world’s second-biggest economy has faltered as COVID flare-ups led to tightening curbs on activity in some cities, while the once mighty property market lurches from crisis to crisis.

Chinese manufacturers continue to wrestle with high raw material prices, which are squeezing profit margins, as the export outlook remains clouded with fears of a global recession.

China’s southern megacity of Shenzhen has vowed to “mobilize all resources” to curb a slowly spreading COVID outbreak, ordering strict implementation of testing and temperature checks, and lockdowns for COVID-hit buildings.

The port city of Tianjin, home to factories linked to Boeing and Volkswagen, and other areas tightened curbs this month to fight new outbreaks.

According to World Economics, the lockdown measures had some impact on 41% of Chinese companies in July, though its index of manufacturing business confidence rose significantly from 50.2 in June to 51.7 in July.

Source: Voice of America

Nichelle Nichols, Lieutenant Uhura on ‘Star Trek,’ Dies at 89

Nichelle Nichols, a groundbreaking Black actress who played communications officer Nyota Uhura with cool authority on the popular 1960s series “Star Trek,” has died at 89.

Her son, Kyle Johnson, announced the death on the official uhura.com website, saying, “Last night, my mother, Nichelle Nichols, succumbed to natural causes and passed away. Her light, however, like the ancient galaxies now being seen for the first time, will remain.”

A family spokesman said Nichols died in Silver City, New Mexico, where she had been living with her son.

Tributes poured in quickly, including from a long list of devoted “Trekkies.”

William Shatner, who played the USS Enterprise’s Captain James T. Kirk, sent his condolences to Nichols’ family.

“She was a beautiful woman & played an admirable character that did so much for redefining social issues both here in the US & throughout the world. I will certainly miss her.”

George Takei, who as helmsman Sulu shared the bridge with Lieutenant Uhura, called her “trailblazing and incomparable.”

And U.S. President Joe Biden said Nichols “redefined what is possible for Black Americans and women.”

“Our nation is forever indebted to inspiring artists like Nichelle Nichols, who show us a future where unity, dignity, and respect are cornerstones of every society,” he said in a statement.

Nichols made history with one of the first interracial kisses on U.S. television – a 1968 embrace shared with Shatner (a kiss deemed worthy of a separate entry in Wikipedia).

Martin Luther King Jr. himself once praised Nichols, who broke ground with her powerful performance at a time when Black actors more often were cast as servants or criminals.

‘An equal role’

Nichols, who had trained in ballet and musical theater, at one point told “Star Trek” creator Gene Roddenberry that she wanted to quit the show to return to the theater.

But when she mentioned that to King, in a chance meeting recounted by the Hollywood Reporter: “All the smile came off his face and he said, ‘You can’t do that. Don’t you understand, for the first time, we’re seen as we should be seen? You don’t have a Black role. You have an equal role.'”

She stayed.

Nichols worked as a recruiter for NASA – which reached out to her after she had criticized its lack of diversity – and successfully encouraged several talented African Americans and women of all races to consider careers with the space agency.

NASA paid tribute to her legacy in a tweet Sunday evening, calling her a “trailblazer and role model” who “symbolized to so many what was possible.”

The National Air and Space Museum also praised her work beyond the screen.

“She was an inspiration to many, not just for her groundbreaking work on Star Trek but also through her work with NASA to recruit women and people of color to apply to become astronauts,” the museum tweeted.

While best known as Uhura, Nichols had a varied career, dancing with Sammy Davis Jr. in “Porgy and Bess,” appearing on the NBC series “Heroes” and recording an album.

She also played Uhura – a name taken from the Swahili for “freedom” – in the first six “Star Trek” movies.

The Smithsonian, the U.S. national museum network, shared a picture on Twitter of the red space jacket Nichols wore as Uhura on screen, adorned with the iconic “Star Trek” pin, which is now on display at the National Museum of African American History and Culture in Washington.

Source: Voice of America

US, Japan to Set Up Research Center for Next Semiconductors

The United States and Japan launched a new high-level economic dialogue Friday aimed at pushing back against China and countering the disruption caused by Russia’s invasion of Ukraine.

The two longtime allies agreed to establish a new joint research center for next-generation semiconductors during the so-called economic “two-plus-two” ministerial meeting in Washington, Japanese Trade Minister Koichi Hagiuda said.

U.S. Secretary of State Antony Blinken, U.S. Commerce Secretary Gina Raimondo, Japanese Foreign Minister Yoshimasa Hayashi and Hagiuda also discussed energy and food security, the officials said in a news briefing.

“As the world’s first- and third-largest economies, it is critical that we work together to defend the rules-based economic order, one in which all countries can participate, compete and prosper,” Blinken told the opening session.

Hagiuda said “Japan will quickly move to action” on next-generation semiconductor research and said Washington and Tokyo had agreed to launch a “new R&D organization” to establish a secure source of the vital components.

The research hub would be open for other “like-minded” countries to participate in, he said.

The two countries did not immediately release additional details of the plan, but Japan’s Nikkei Shimbun newspaper earlier said it would be set up in Japan by the end of this year to research 2-nanometer semiconductor chips. It will include a prototype production line and should begin producing semiconductors by 2025, the newspaper said.

“As we discussed today, semiconductors are the linchpin of our economic and national security,” said Raimondo, adding that the officials had discussed collaboration on semiconductors, “especially with respect to advanced semiconductors.”

Taiwan now makes the vast majority of semiconductors under 10 nanometers, which are used in products such as smart phones, and there is concern about the stability of supply should trouble arise involving Taiwan and China, which views the island as part of its territory.

The United States and Japan said in a joint statement they would work together “to foster supply chain resilience in strategic sectors, including, in particular, semiconductors, batteries, and critical minerals.” They vowed to “build a strong battery supply chain to lead collaboration between like-minded countries.”

On ties with Russia, Hagiuda said he gained U.S. understanding about Japan’s intention to keep its stake in the Sakhalin-2 oil and gas project despite sanctions against Moscow by Washington, Tokyo and others following the Ukraine invasion.

“There are voices calling for withdrawal. But it would mean our stake goes to a third country and Russia earns an enormous profit. We explained how keeping our stake is in line with sanctions, and I believe we gained U.S. understanding,” he said.

Japanese trading houses Mitsui & Co and Mitsubishi Corp hold a combined 22.5% stake in the project.


Source: Voice of America

US Rules Out Summer COVID Boosters for Adults Under 50 to Focus on Fall

U.S. regulators said Friday they are no longer considering authorizing a second COVID-19 booster shot for all adults under 50 this summer, focusing instead on revamped vaccines for the fall that will target the newest viral subvariants.

Pfizer and Moderna expect to have updated versions of their shots available as early as September, the Food and Drug Administration said in a statement. That would set the stage for a fall booster campaign to strengthen protection against the latest versions of omicron.


The announcement means the U.S. won’t pursue a summer round of boosters using the current vaccines for adults under 50, as some Biden administration officials and outside experts previously suggested. They had argued that another round of shots now could help head off rising cases and hospitalizations caused by the highly transmissible omicron strains.

Currently, all Americans ages 5 and over are eligible for a booster shot five months after their initial primary series. Fourth doses of the Pfizer or Moderna shots — a second booster — are recommended for Americans 50 and older and for younger people with serious health issues that make them more vulnerable to COVID-19.

The FDA urged eligible adults who haven’t been boosted to get their extra shot now: “You can still benefit from existing booster options and leave time to receive an updated booster in the fall,” the agency said in a statement.

The White House has also emphasized that getting a fourth dose now won’t impact anyone’s ability to get omicron-targeted shots once they’re made available — although how long it’s been since their last dose will play a role in how soon they’re eligible.

Two omicron subvariants, BA.4 and BA.5, are even more contagious than their predecessors and have pushed new daily cases above 125,000 and hospitalizations to 6,300. Those are the highest levels since February, though deaths have remained low at about 360 per day, thanks to widespread immunity and improved treatments against the virus.

The subvariants are offshoots of the strain responsible for nearly all of the virus spread in the U.S. this year.

All the COVID-19 vaccines given in the U.S. until now have been based on the original version of the virus that began spreading across the country in early 2020.

In June, the FDA told the vaccine makers that any boosters for the fall would have to combine protection against omicron BA.4 and BA.5 and the original coronavirus strain. Both manufacturers have been speeding their production and data gathering to have those so-called bivalent vaccines ready for the fall.

The FDA and the Centers for Disease Control and Prevention would have to sign off on revamped shots before their launch.

The U.S. has a contract to buy 105 million doses of the Pfizer combination shots once they’re ready, and 66 million of Moderna’s version. But how soon large amounts would become available isn’t clear. The government contracts include options to purchase 300 million doses each but reaching that total will require more funding from Congress, the Biden administration said.

As for timing, getting a booster too soon after the previous dose means missing out on its full benefit — something policymakers will have to take into consideration when rolling out revamped shots.

The White House has at times been frustrated by the pace of decision-making at the FDA and CDC, most notably last summer, when the regulators took weeks to decide whether to authorize the first booster dose for U.S. adults. Privately, West Wing officials believe the delay cost lives, preventing optimum protection amid the delta and omicron surges, and also fed into doubts about vaccine and booster effectiveness that affected their uptake.

In recent weeks, some of those frustrations have bubbled up again, as regulators considered whether to recommend a fourth shot for all adults, not just those at highest risk from the virus. Some in the White House believe that the additional dose would have helped somewhat with the rapidly spreading BA.5 subvariant, and also lift the confidence of anyone worried that their protection had waned.

Still, officials across the government have acknowledged the risks of vaccine fatigue among Americans, including tens of millions who still haven’t received their first booster. Government figures show less than half of those eligible for a booster have gotten that third shot.

Source: Voice of America

Syinix Launches World First Machine that can cook Africa Staple Food: Banku, FUFU etc.

ACCRA, Ghana, July 29, 2022 /PRNewswire/ — According to the study, 83% of African eat a variety of Swallow foods (such as Banku, fufu,etc.) as their staple food. For most of African, however, making swallow food is a difficult process, as users have to stir the food throughout, and the whole process is time-consuming as well. Therefore, a full-automatic Swallow Maker that are hands-free is the irresistible trend. On 28th July, Syinix officially unveiled the world’s first Swallow Maker in Accra, Ghana, creating a new era of fully automated cooking swallow food in Africa.

Syinix World's First Swallow Maker

Swallow Maker

Syinix Managing Director of West Africa Justin said at the launch event:” Welcome to witness this historic moment with Syinix. Swallow Maker is not only the first model for Syinix, but also the world’s first automatic swallow food cooking machine. Both the product concept and the functions of Swallow Maker are unique. It is fully automated, multifunctional, easy to clean and large capacity to bring easy and convenient cooking experience for African families.

Syinix is a high-end home appliance brand of Transsion Holdings, which also owns three major famous mobile phone brands in Africa: Tecno*, Infinix*, Itel*. Syinix has now spread to more than 20 countries in Africa, and it’s features of high quality and innovation , are becoming increasingly competitive and promising in the African market in recent years.
Syinix’s product team visited over 10 African countries and found that some of the swallow food process still involved using mortar and pestle, which requires two people to beat and turn the food constantly. Recently people start using pot and spoons which still requires manual mixing. After discovering these problems, Syinix’s product team eventually developed the world’s first fully automatic swallow maker after more than 2 years hard work.

Full automation:
Swallow maker as a fully automated machine, requires simple operations before delicious food is made. User will only need to pour the ingredients into the machine proportionally, and the rest of the human work is replaced by the machine. Compared to traditional production methods, swallow maker stops users from constantly stirring thus, can spend more time with their families and enjoy life.

Multi-function:
Another function of Swallow maker is that it supports the production of all-purpose swallow food to ensure the taste and eating habits in different parts of Africa.For example, banku , fufu and konkonte in Ghana; eba, pounded yam, amala and semolina in Nigeria, and ugali in Kenya. In addition, Swallow maker supports creative cooking, allowing users to try out more new creative ingredients and recipes.

Large capacity & Easy to clean:
The “Swallow Maker” is a high-capacity device that support preparing meals for a family of four or five, which meets the needs of the majority African families. It’s removable knife set and non-stick coating design makes it convenient to clean up food residue.

Others functions:
Syinix takes full consideration of user needs in the whole process of developing Swallow Maker. The metal pot body and no modified material, as well as the special power operation mechanism, ensures the safe and stable production process of the machine. Other ingenious designs, such as the appearance of the machine, is inspired by traditional African handicrafts, and can effectively prevent it from falling off easily when holding or moving it. Syinix swallow maker successfully got a number of patents and the 2022 German Red Dot Design Award. It also support 13-month warranty period by Syinix’s after-sell service partner Carlcare* that guarantees the whole use experiences.

Purchase channels:
More details, visit Syinix’s official website: https://gh.syinix.com/products/syinix-swallow-maker-worlds-first-one.

Photo – https://mma.prnewswire.com/media/1868953/Syinix_World_s_First_Swallow_Maker.jpg

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

DURHAM, N.C., July 28, 2022 (GLOBE NEWSWIRE) — Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through November 5, 2021).

“These results are encouraging as CAB efficacy was sustained during the 12 months following unblinding, confirming a high level of protection against HIV acquisition among study participants assigned female at birth,” said Dr. Sinead Delany-Moretlwe, HPTN 084 protocol chair, director of research at Wits RHI, and research professor at the University of the Witwatersrand in Johannesburg, South Africa.

HPTN 084 is an ongoing Phase 3 randomized, controlled trial that previously demonstrated the superiority of ViiV Healthcare’s long-acting cabotegravir compared to daily oral tenofovir/emtricitabine (TDF/FTC) for HIV prevention in individuals assigned female at birth. The blinded portion of the trial was stopped at a planned interim review in November 2020 due to evidence of superior efficacy when compared to daily oral TDF/FTC. Participants were subsequently unblinded and continued their original randomized study regimen pending a protocol amendment to offer open-label CAB.

“HIV infection continues to threaten the health of women worldwide,” said Dr. Myron Cohen, HPTN co-principal investigator, and director of the Institute for Global Health at the University of North Carolina in Chapel Hill. “Empowering women with safe and effective PrEP options is critical to reducing HIV as a global health threat.”

HPTN 084 enrolled 3,223 cisgender women at research sites in Botswana, Eswatini, Kenya, Malawi, South Africa, Uganda, and Zimbabwe. Twenty-three incident infections (3 CAB, 20 TDF/FTC) were detected in the 12-month unblinded period. Of these, two (1 CAB, 1 TDF/FTC) were determined to have occurred during the blinded phase. Only one of the CAB cases (blinded phase case) had ever received an injection. An additional 83 confirmed pregnancies (43 CAB, 40 TDF/FTC) occurred in the unblinded period. No congenital anomalies were reported.

“The additional pregnancy incidence data highlight the importance of establishing the safety and pharmacology of CAB among pregnant individuals,” said Dr. Wafaa El-Sadr, HPTN co-principal investigator, director of ICAP, and professor of epidemiology and medicine at Columbia University in New York.

HPTN 084 was co-funded by NIAID, the Bill & Melinda Gates Foundation, and ViiV Healthcare. Study product was provided by ViiV Healthcare and Gilead Sciences, Inc. Three other NIH institutes also collaborated on HPTN 084: the National Institute of Mental Health, the National Institute on Drug Abuse, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

About HPTN

The HIV Prevention Trials Network (HPTN) is a worldwide collaborative clinical trials network that brings together investigators, ethicists, community members, and other partners to develop and test the safety and efficacy of interventions designed to prevent the acquisition and transmission of HIV. The U.S. National Institute of Allergy and Infectious Diseases, the U.S. National Institute of Mental Health, Office of The Director, the U.S. National Institute on Drug Abuse, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, all part of the U.S. National Institutes of Health, co-fund the HPTN. The HPTN has collaborated with more than 85 clinical research sites in 19 countries to evaluate new HIV prevention interventions and strategies in populations with a disproportionate HIV burden. The HPTN research agenda – more than 50 trials ongoing or completed with over 161,000 participants enrolled and evaluated – is focused primarily on discovering new HIV prevention tools and evaluating integrated strategies, including biomedical interventions combined with behavioral risk reduction interventions and structural interventions. For more information, visit hptn.org.


Eric Miller
HIV Prevention Trials Network (HPTN)
9193846465
emiller@fhi360.org

Chargebee Enables Subscription Businesses to Combat Economic Turmoil with 2022 Summer Product Release

New Product Launch Leans Heavily on Customer Retention, Monetization and Streamlining Revenue Operations

San Francisco, Calif., July 28, 2022 (GLOBE NEWSWIRE) — Chargebee, the leading subscription management platform, today announced its Summer 2022 Product Release. The slate of new products and features is focused on enabling high-performing subscription businesses to monetize their existing customers and fend off the growing threats of a tumultuous economy. These new products help businesses build their cash reserves and maintain their customer base at a time when many businesses – and their customers – are struggling with the realities of inflation and drying up of venture capital, the lingering effects of COVID-19 and a decimated global supply chain.

The centerpiece of Chargebee’s Summer 2022 Product Release is Chargebee Retention, formerly Brightback, which along with Chargebee Receivables (numberz), and RevRec (RevLock), all acquired by Chargebee over the last 18 months, represent Chargebee’s initial foray into becoming a true multi-product company.

Chargebee Retention allows businesses to focus on keeping the customers they already have at a time when both businesses and consumers are being forced to evaluate everything in their portfolios and make difficult decisions. Chargebee Retention enables businesses to customize cancellation experiences with offers geared towards continuing the customer relationship and allows businesses to test out personalized retention-magnet strategies to minimize voluntary churn and strengthen customer lifetime value with an ROI of as much as 800%.

“For subscription businesses, acquiring new customers is at least 2.5 times more expensive than upselling or expanding an existing customer. This factor can be even higher with intelligent automation that decreases customer churn while increasing the chances of expansion,” said Mark Thomason, IDC Research Director responsible for Digital Business Models and Monetization practice. “While these retention capabilities are critical during these tumultuous times, keeping happy customers is always in vogue.”

Chargebee Receivables helps businesses improve their cash flow management processes by automating accounts receivable workflows. Subscription businesses will now be able to efficiently automate their entire accounts receivables workflow and process from purchase to payment. In addition, Chargebee Receivables also lets businesses proactively engage with customers on predicted payment failure to minimize involuntary churn and increase customer retention.

“Customer retention has become an even bigger focus for us over the past year or so,” said Bob Viscount, Vice President at Silhouette U. “The economy has changed a lot, and we’ve been looking for a solution that helps mitigate some of the cancellations we’ve been seeing.  Customers have chosen to cancel due to cost and having an option to deflect some of these cancellations with a tailored offer in the moment has been a huge boost to our business. Chargebee Retention has proven to be a value-add to our business and has allowed us to provide customers with a comprehensive review of what they’d be giving up while also leveraging offers when needed. The results in a very short amount of time have convinced me that this needs to be a critical component to our business moving forward.”

The volatility of today’s market landscape has forced businesses to become adaptable and nimble in ways they hadn’t previously expected, tinkering with package and feature offerings and providing new and different services to customers at different price points.  The new Chargebee Entitlements offers businesses more control over this new path and enables them to upsell to existing customers by showing them value. Chargebee Entitlements enables businesses to “value-test” and experiment with different packaging and pricing options, better control feature launches with roll-outs to small subsets of customers, and go to market faster. Chargebee Entitlements helps go-to-market teams provide feature access to customers beyond their plan on the flip of a switch, which can be used to incentivize plan upgrades and free-to-paid conversions.

“We’ve spent months engaging with our customers, learning the ins and outs of their businesses and working with them to determine what types of tools they want and need to face their current challenges head-on,” said John Pearce, Vice President of Product Management at Chargebee. “In those conversations, the focus almost always homed in on retaining customers, building long-lasting customer relationships and understanding how Chargebee can help businesses monetize their existing customer base. Chargebee Retention, Chargebee Receivables and Chargebee Entitlements are a direct result of our findings and our desire to give our customers exactly what they need to build and scale their businesses, even in these trying times.”

The complete list of features in Chargebee’s Summer 2022 Product Release, which also includes in-app purchase management, multi-entity management, integration with PandaDoc to manage quote-based subscription workflows, a RevRec integration that helps businesses recognize revenue in local currency and avoid challenges that hinder growth, and RevRec’s ASC 606 expense recognition, can be found here: https://www.chargebee.com/summer-release-2022/

About Chargebee

Chargebee is the subscription management platform that automates revenue operations of over 4,500 subscription-based businesses from startups to enterprises. The SaaS platform helps subscription businesses across verticals, including SaaS, eCommerce, e-learning, IoT, Publications, and more, manage and grow revenue by automating subscription billing, invoicing, payments, and revenue recognition operations, provides key metrics, reports, and business insights and now offers Chargebee Retention and Chargebee Receivables. Founded in 2011, Chargebee counts businesses, like Okta, Freshworks, Calendly, and Study.com amongst its global customer base. Learn more about Chargebee at www.chargebee.com.

Jake Katz
Chargebee
jake.katz@chargebee.com

WHO: New Vaccines Must Be Developed to Keep Pace With COVID Variants

The World Health Organization is calling for greater investment in the development of new vaccines to keep pace with the rapidly evolving variants of the coronavirus.

As world attention is focused on the monkeypox outbreak, WHO chief Tedros Adhanom Ghebreyesus warns the COVID-19 pandemic is far from over. He says new tools must be developed to curb this deadly disease while public health measures that are known to work must be maintained and strengthened.

He says one of the most effective ways to save lives is to vaccinate the right groups first. By this he means health workers, older people, and other at-risk groups such as those with underlying health conditions.

He notes COVID-19 cases and deaths have been increasing for the last five weeks. The latest WHO report puts the number of confirmed global cases at nearly 566 million, including more than 6.3 million deaths.

Tedros says several countries also are reporting increasing hospitalizations, following waves of transmission driven by omicron subvariants. “While vaccines have saved countless lives, they have not substantially reduced transmission. So, it is vital for governments and the private sector to continue collaborating and investing in the development of new vaccines that prevent both infection and disease.”

Tedros adds vaccines should be developed that can be delivered more easily, such as through nasal sprays or drops.

The WHO executive director for health emergencies, Mike Ryan, says more attention must be paid to pandemic preparedness. He says risks from diseases such as COVID-19, monkeypox, Marburg, and polio are accelerating because nations tend to be reactive, rather than active in tackling these diseases.

“I think we need to really take a much more systematic look at how we prioritize pathogens for the future and then how we invest… It will cost money and it does cost money. But it is a fantastic investment in protecting us down the line. And a dollar spent in preparedness is worth a thousand dollars spent on response.”

WHO chief Tedros agrees. He urges all countries to assess and strengthen their readiness and response plans for future waves of transmission.

He adds that as new vaccines and other COVID-19 tools are developed, it is crucial they are equitably available in all countries.

Source: Voice of America